HRMY
Harmony Biosciences Holdings, Inc.
Data as of 2026-07-21
Company attributes
Price
Interactive 5-year price history chart for HRMY. Latest close $36.84.
Pillar breakdown
0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)
- QualityProfit margins & asset efficiency75ExceptionalHealth Care median (n=166) 50
- ValuePrice vs fundamentals81ExceptionalHealth Care median (n=166) 52
- GrowthRevenue & earnings trajectory65StrongHealth Care median (n=166) 50
- MomentumRecent price strength42AverageHealth Care median (n=166) 49
- HealthBalance sheet & solvency88ExceptionalHealth Care median (n=166) 57
- ProfitabilityROE, ROA, ROIC80ExceptionalHealth Care median (n=166) 48
- TechnicalTrend & volatility signals51AverageHealth Care median (n=166) 56
- RiskVolatility & drawdown profile35WeakHealth Care median (n=166) 46
Pillars not shown: Sentiment, ML (Phase 5+).
Recent regulatory events
- Going-concern disclosure (10-K)Annotate
Risk Summary
Low- Restatement history (10-K/A, 5y)[restatement_history]
- Beneish M-score warning band[beneish_high]
Rolls up Phase 4.5 earnings-manipulation defenses (Sloan · Beneish · Dechow · REM · restatement · late-filing · earnings- quality time-series) into a single 0-100 risk index. The soft composite penalty (max 10 pts) is informational only — the ranking uses the raw composite score per project Rule 16.
Fair price check
6 different valuation methods each estimate what HRMYshould be worth, then we compare to today's price.
- P/B multiplesUndervaluedthinks it's a bargain — estimates $83.08, about 126% above today
- EV/EBITDAUndervaluedthinks it's a bargain — estimates $81.96, about 122% above today
- P/E multiplesUndervaluedthinks it's a bargain — estimates $59.37, about 61% above today
- DCF (2-stage)Undervaluedthinks it's a bargain — estimates $55.92, about 52% above today
- Graham (defensive)Overvaluedthinks it's expensive — estimates $28.06, about 24% below today
- Residual IncomeOvervaluedthinks it's expensive — estimates $24.05, about 35% below today
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
- Median fair
- $57.64
- Margin of safety(vs fair value)
- +36.1%
- Max (ex-outliers)
- $83.08
- Tangible BVPS
- $14.28
- Beneish M-score (warning band)
- Restatement history
Median of all applicable methods (current price $36.84). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.
Supporting dataRaw fundamentals & data-quality provenance behind the scores above
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $2.13B |
| Revenue (TTM) | $899.11M |
| Net income (TTM) | $145.62M |
| Operating cash flow (TTM) | $341.97M |
| CapEx (TTM) | $310.00K |
| Free cash flow (TTM)CFO − CapEx | $341.66M |
| Total assets | $1.27B |
| Total liabilities | $361.48M |
| Stockholders' equity | $910.35M |
| Cash & equivalents | $589.40M |
| Shares outstanding | 57.89M |
| EPS (basic) | $2.52 |
| EPS (diluted) | $2.52 |
| P/E ratio (TTM) | 14.65 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-05-07
- Latest period end
- 2026-05-05
- Filing lag
- 75 days
- Missing metrics
- 2(dividends_paid, goodwill)
Composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars are reserved for a later phase; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.